RT @NCICancerBio: Using experimental models in a study supported by our division, scientists @UW, @fredhutch, et al. identified SRRM3 (an #…
RT @NCICancerBio: Using experimental models in a study supported by our division, scientists @UW, @fredhutch, et al. identified SRRM3 (an #…
Using experimental models in a study supported by our division, scientists @UW, @fredhutch, et al. identified SRRM3 (an #RNAsplicing factor) as a key inducer of cellular plasticity in #prostatecancer with neuroendocrine features @CR_AACR https://t.co/NLkdQ
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine #ProstateCancer. https://t.co/d5DrGO5bP9
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer https://t.co/OiRVDj2A6K
RT @Prostate_IPCR: IPCR researchers: RNA splicing factors SRRM3 and SRRM4 distinguish molecular phenotypes of castration-resistant neuroe…
IPCR researchers: RNA splicing factors SRRM3 and SRRM4 distinguish molecular phenotypes of castration-resistant neuroendocrine prostate cancer https://t.co/cW2CsSuky9
RT @science_seattle: 💡 Research out of @uwurology has uncovered RNA splicing factors expressed in early #neuroendocrine differentiation and…
💡 Research out of @uwurology has uncovered RNA splicing factors expressed in early #neuroendocrine differentiation and provides a framework to molecularly classify diverse neuroendocrine phenotypes in #ProstateCancer. ➡️ https://t.co/HDEn0TJ0Ky https://t.
🔎 In this @CR_AACR paper, @UW researchers provide a framework to molecularly classify diverse neuroendocrine phenotypes in metastatic castration-resistant #prostate cancer. 📍 https://t.co/HDEn0TJ0Ky https://t.co/cTWvl8OxWw
Research from @CR_AACR! @uwurology scientists including Dr. Colm Morrissey nominate SRRM3 as the principal REST 🛏️ splicing factor expressed in early neuroendocrine differentiation. #ProstateCancer 🔖 https://t.co/gGC22Pe9SX https://t.co/MEsCBiMDZS
New article: RNA splicing factors SRRM3 and SRRM4 distinguish molecular phenotypes of castration-resistant neuroendocrine prostate cancer https://t.co/wYzeopTh8z #prostatecancer #oncology https://t.co/fg4fygOlaT